000 01346 a2200373 4500
005 20250512223456.0
264 0 _c19831123
008 198311s 0 0 eng d
022 _a0333-1024
024 7 _a10.1177/03331024830030S123
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAylward, M
245 0 0 _aOn the treatment of migraine. Pharmacokinetic-pharmacodynamic relationships for a programmed release formulation of dihydroergotamine administered orally in the human.
_h[electronic resource]
260 _bCephalalgia : an international journal of headache
_cAug 1983
300 _a146-50 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aBiological Availability
650 0 4 _aChemical Phenomena
650 0 4 _aChemistry
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDihydroergotamine
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aMigraine Disorders
_xdrug therapy
700 1 _aDavies, D E
700 1 _aMaddock, J
700 1 _aRobinson, P R
700 1 _aJones, M
773 0 _tCephalalgia : an international journal of headache
_gvol. 3 Suppl 1
_gp. 146-50
856 4 0 _uhttps://doi.org/10.1177/03331024830030S123
_zAvailable from publisher's website
999 _c6616412
_d6616412